Scientists reveal likely cause of childhood leukaemia
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, following more than a century of controversy about its origins.
May 21, 2018
0
3329
The Institute of Cancer Research (the ICR) is a cancer research university located in London, United Kingdom and a constituent college of the federal University of London. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA. Together with the Royal Marsden Hospital the ICR forms the largest comprehensive cancer centre in Europe, and was ranked first amongst all British higher education institutions in the Times Higher Education 2008 Research Assessment Exercise Table of Excellence. In addition to its research activities the ICR provides both taught postgraduate degree programmes and research degrees and currently has around 340 students. It occupies two sites, one in Chelsea in Central London and one in Sutton in southwest London, and had a total income of £85.4 million in 2010/11, of which £50.5 million was from research grants and contracts.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, following more than a century of controversy about its origins.
May 21, 2018
0
3329
A new genetically engineered virus has delivered a one-two punch against advanced cancers in initial findings from a phase I trial.
Sep 23, 2022
0
3410
A new precision medicine targeting cancer's ability to repair its DNA has shown promising results in the first clinical trial of the drug class.
Jun 22, 2020
0
1108
A new cancer database containing 1.7 billion experimental results will utilise artificial intelligence similar to the technology used to predict the weather to discover the cancer treatments of the future.
Nov 12, 2013
0
0
An immunotherapy drug has been hailed as a potential 'game changer' after being found to greatly improve survival for patients with relapsed head and neck cancer - a disease which is notoriously difficult to treat.
Oct 9, 2016
0
1131
Giving people with bladder cancer chemotherapy and radiotherapy at the same time helps stop cancer from coming back, long-term results of a 10-year study confirm.
Aug 2, 2022
0
3
Scientists have shown it is possible to reverse a key process that allows pancreatic cancer cells to grow and spread around the body.
Jun 29, 2022
0
223
Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.
Mar 9, 2019
1
354
Scientists have developed the most accurate computing method to date to reconstruct the patchwork of genetic faults within tumors and their history during disease development, in new research funded by Cancer Research UK ...
Sep 3, 2020
0
214
A new study could help to answer an important riddle in our understanding of genetics: why research to look for the genetic causes of common diseases has failed to explain more than a fraction of the heritable risk of developing ...
Feb 13, 2014
0
0